Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — April 2026

Biotek-snakken — April 2026

Planlagt Fastgjort Låst Flyttet Biotek-snakken
54 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #36

    De kommende år vil vise om Genmab valgte rigtigt med at gå den vej - personligt har de skuffet lidt med udvikling af egne kandidater, men hvis potosemtamab og RinaS går hele vejen, så skal det nok blive godt.

    1 Reply Last reply
    0
    • L Offline
      L Offline
      lahn1
      wrote on sidst redigeret af
      #37

      Jo det er jo netop Ecor1 der har styret hele strategiskiftet, bl.a ved nye folk i BD og de nye royalty pharma aftaler. EcoR1 er ved at forvandle Zymeworks fra et rodet biotekselskab til et rent, cashflow-genererende aktiv — præcis den type virksomhed, Big Pharma køber. Samme metode blev brugt på Horizon pharma. Mindre risikofyldt R&D, mere stabil cashflow
      .vil med tiden efter en phase 1 eller 2 deal på zw191 ligne et et finansielt aktiv, ikke et usikkert biotech-bet.

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #38

        PHOTOCURE: ABG oppgraderer aksjen fra hold til kjøp og øker kursmålet til NOK 80 (72).

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #39

          Er der nogen der ved hvad den store stigning i Ascelia kommer af. Kan ikke finde noget på deres hjemmeside.

          1 Reply Last reply
          0
          • F Offline
            F Offline
            Fandel
            wrote on sidst redigeret af
            #40

            Godmorgen...

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #41

              Novo og Lilly kan se opkomling blive børsnoteret https://proinvestor.com/investornyt/1433039/novo-og-lilly-kan-se-opkomling-blive-borsnoteret

              1 Reply Last reply
              0
              • L Offline
                L Offline
                LP90
                wrote on sidst redigeret af
                #42

                Godmorgen 🙂

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  LP90
                  wrote on sidst redigeret af
                  #43

                  Godmorgen 🙂

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    LP90
                    wrote on sidst redigeret af
                    #44

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      LP90
                      wrote on sidst redigeret af
                      #45

                      Godmorgen 🙂

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        LP90
                        wrote on sidst redigeret af
                        #46

                        Godmorgen 🙂

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bibob
                          wrote on sidst redigeret af
                          #47

                          God morgen. 🙂

                          1 Reply Last reply
                          0
                          • L Offline
                            L Offline
                            LP90
                            wrote on sidst redigeret af
                            #48

                            Godmorgen 🙂

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #49

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • T Offline
                                T Offline
                                Thesis
                                wrote on sidst redigeret af
                                #50

                                Initiator Pharma A/S rapporterer fremskridt i patientrekrutteringen til fase 2a-studie i vulvodyni https://www.nordnet.dk/markedet/nyheder/4a963de2-45da-4f01-9de5-b12683953745

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #51

                                  Flot opt-out aftale til Protagonist

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #52

                                    Link Preview Image
                                    Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration

                                    Opt-out election makes Protagonist eligible for $200 million upon exercise and an additional $200 million upon FDA approval of rusfertide for polycythemia vera Approval would also trigger a $75 million milestone payment, bringing total potential cash ...

                                    favicon

                                    Yahoo Finance (finance.yahoo.com)

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      LP90
                                      wrote on sidst redigeret af
                                      #53

                                      Godmorgen 🙂

                                      1 Reply Last reply
                                      0
                                      • T Offline
                                        T Offline
                                        Thesis
                                        wrote on sidst redigeret af
                                        #54

                                        Initiator Pharma A/S: Enrolment on track - fair value range 6,8–9,3 SEK (DNB Carnegie)
                                        Recruitment in the important vulvodynia study appears to be on track, with half of the planned patients already dosed. We find the positive development encouraging. We believe a positive outcome could represent a key value inflection point, and estimate peak sales of approximately USD1.6bn, risk-adjusted at a 15% LOA. https://access.dnbcarnegie.com/publication/e46d158f-68fe-43f0-58cb-08dea508df61

                                        1 Reply Last reply
                                        0
                                        • L Offline
                                          L Offline
                                          LP90
                                          wrote on sidst redigeret af
                                          #55

                                          Godmorgen 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper